The correct measurement of oxygen saturation at high altitude

  • Markus TannheimerEmail author
  • R. Lechner
Sleep Breathing Physiology and Disorders • Original Article



Compared to measurements at sea level, measurement of oxygen saturation by pulse oximetry (SpO2) at altitude differs fundamentally because of the cyclical course of SpO2, caused by periodic breathing. Therefore, the determination of a representative SpO2 value is difficult. In the literature, recommendations for a standardized measurement procedure are missing; different studies measure SpO2 in different ways.

Key question

Does the visually determined SpO2 value correlate with the actual average of the measurement interval?


Four participants of an expedition (6013 m; Pakistan), familiar with pulse oximetry at altitude, wrote down the representative value of the measurement interval of 3 min (SpO2visual) according to their individual observation. The used pulse oximeter saved the value for SpO2 every 4 s. Based on this, the calculated mean (SpO2memory) was compared to SpO2visual after finishing the expedition (128 measurements > 2500 m).


The spread of the single values within the measurement interval is high (in single cases up to 17%-points) in case of insufficient acclimatization. With increasing acclimatization, the measured values stabilize. SpO2visual differs only marginally (− 0.4%-points; ± 0.8) compared to SpO2memory.


The correct pulse oximetric determination of SpO2 at high altitude requires a standardized measurement procedure; the investigator is familiar and trained. Anyway, the measurements have to be done in the continuous mode of the pulse oximeter over a sufficient timeframe (3 SpO2-fluctuation cycles; 2–3 min). We recommend to record the maximum and the minimum value of the measurement interval and to use a pulse oximeter device with memory function.


Pulse oximetry Oxygen saturation High altitude Acclimatization High altitude illness AMS 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Recommendations of the Commission on Professional Self-Regulation in Science (DFG: Deutsche Forschungsgemeinschaft) [24] and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Luks AM, Swenson ER (2011) Pulse oximetry at high altitude. High Alt Med Biol 12(2):109–119. CrossRefGoogle Scholar
  2. 2.
    Saito S, Shimada H, Imai T, Futamata Y, Yamamori K (1995) Estimation of the degree of acclimatization to high altitude by a rapid and simple physiological examination. Int Arch Occup Environ Health 67(5):347–351CrossRefGoogle Scholar
  3. 3.
    Bärtsch P (2005) Pulsoximetrie und akute Bergkrankheit. Flug- und Reisemedizin 44:22–23Google Scholar
  4. 4.
    Basnyat B (2014) Pro: pulse oximetry is useful in predicting acute mountain sickness. High Alt Med Biol 15(4):440–441CrossRefGoogle Scholar
  5. 5.
    Windsor JS (2012) Pulse oximetry and predicting acute mountain sickness: are we asking the right questions? Wilderness Environ Med 23(2):112–113CrossRefGoogle Scholar
  6. 6.
    Windsor JS, Rodway GW (2014) Con: pulse oximetry is useful in predicting acute mountain sickness. High Alt Med Biol 15(4):442–443CrossRefGoogle Scholar
  7. 7.
    Küpper T, Schöffl V, Netzer N (2008) Cheyne stokes breathing at high altitude: a helpful response or a troublemaker? Sleep Breath 12(2):123–127. CrossRefGoogle Scholar
  8. 8.
    Cristancho E, Riveros A, Sanchez A, Penuela O, Böning D (2016) Diurnal changes of arterial oxygen saturation and erythropoietin concentration in male and female highlanders. Physiol Rep 4(17):e12901. CrossRefGoogle Scholar
  9. 9.
    Tannheimer M, van der Spek R, Brenner F, Lechner R, Steinacker JM, Treff G (2017) Oxygen saturation increases over the course of the night in mountaineers at high altitude (3050–6354 m). J Travel Med 24.
  10. 10.
    O'Connor T, Dubowitz G, Bickler PE (2004) Pulse oximetry in the diagnosis of acute mountain sickness. High Alt Med Biol 5(3):341–348. CrossRefGoogle Scholar
  11. 11.
    Wagner DR, Knott JR, Fry JP (2012) Oximetry fails to predict acute mountain sickness or summit success during a rapid ascent to 5640 meters. Wilderness Environ Med 23(2):114–121. CrossRefGoogle Scholar
  12. 12.
    Burtscher M, Flatz M, Faulhaber M (2004) Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt Med Biol 5(3):335–340. CrossRefGoogle Scholar
  13. 13.
    Karinen HM, Peltonen JE, Kahonen M, Tikkanen HO (2010) Prediction of acute mountain sickness by monitoring arterial oxygen saturation during ascent. High Alt Med Biol 11(4):325–332. CrossRefGoogle Scholar
  14. 14.
    Roach RC, Greene ER, Schoene RB, Hackett PH (1998) Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med 69(12):1182–1185Google Scholar
  15. 15.
    Tannheimer M, Thomas A, Gerngross H (2002) Oxygen saturation course and altitude symptomatology during an expedition to broad peak (8047 m). Int J Sports Med 23(5):329–335. CrossRefGoogle Scholar
  16. 16.
    Faulhaber M, Wille M, Gatterer H, Heinrich D, Burtscher M (2014) Resting arterial oxygen saturation and breathing frequency as predictors for acute mountain sickness development: a prospective cohort study. Sleep Breath 18(3):669–674. CrossRefGoogle Scholar
  17. 17.
    Chen H-C, Lin W-L, Wu J-Y, Wang S-H, Chiu T-F, Weng Y-M, Hsu T-Y, Wu M-H (2012) Change in oxygen saturation does not predict acute mountain sickness on Jade Mountain. Wilderness Environ Med 23(2):122–127CrossRefGoogle Scholar
  18. 18.
    Roeggla G, Roeggla M, Podolsky A, Wagner A, Laggner AN (1996) How can acute mountain sickness be quantified at moderate altitude? [see comments]. J R Soc Med 89(3):141–143CrossRefGoogle Scholar
  19. 19.
    Tannheimer M, Hornung K, Gasche M, Kühlmuss B, Müller M, Welsch H, Landgraf K, Guger C, Schmidt R, Steinacker JM (2012) Decrease of asymmetric dimethylarginine predicts acute mountain sickness. J Travel Med 19(6):338–343. CrossRefGoogle Scholar
  20. 20.
    Tannheimer M, Albertini N, Ulmer HV, Thomas A, Engelhardt M, Schmidt R (2009) Testing individual risk of acute mountain sickness at greater altitudes. Mil Med 174(4):363–369CrossRefGoogle Scholar
  21. 21.
    Nonin_Medical_Inc (2014) PalmSAT 2500 Series. Availabel at:
  22. 22.
    Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310CrossRefGoogle Scholar
  23. 23.
    Mandolesi G, Avancini G, Bartesaghi M, Bernardi E, Pomidori L, Cogo A (2014) Long-term monitoring of oxygen saturation at altitude can be useful in predicting the subsequent development of moderate-to-severe acute mountain sickness. Wilderness Environ Med 25(4):384–391CrossRefGoogle Scholar
  24. 24.
    Deutsche Forschungsgemeinschaft (1998) Recommendations of the commission on professional self-regulation in science: proposals for safeguarding good scientific practice. Available at: (p.8). Accessed Sept 2013

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Sport and Rehabilitation MedicineUniversity of UlmUlmGermany
  2. 2.Department Anesthesiology and Intensive Care MedicineGerman Armed Forces Hospital UlmUlmGermany

Personalised recommendations